PBM significantly reduced the severity of ARDS by decreasing the IL-1β, IL-6 (both in the lungs and plasma), and IL-8 (in the lungs), also lowering the mortality rate [289]. The gene discussed is CXCL8; the disease is acute respiratory distress syndrome.